• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Blood Donation

Donor Deferral Recommendations for HIV Pre-exposure Prophylaxis

In December 2021, the U.S. FDA approved injectable cabotegravir (Apretude) as pre-exposure prophylaxis (PrEP) to prevent HIV transmission.  PrEP, post-exposure…

September 14, 2022

Are WHO Guidelines for Serum Ferritin Levels for Female Blood Donors Too Low?

The current World Health Organization (WHO) guidelines, based on expert opinion with low-grade evidence, define iron deficiency in healthy blood…

July 6, 2022

Educational Materials Help to Retain Donors after a Temporary Deferral

Previous studies have found that temporarily deferred donors sometimes believe that their deferral is permanent.  In order to determine whether…

June 29, 2022

Perfluoroalkyl and Polyfluoroalkyl Levels after Blood Donations

Perfluoroalkyl and polyfluoroalkyl substances (PFASs) are ubiquitous synthetic compounds found in many products, including Teflon, water-resistant materials, paints, and firefighting…

April 27, 2022

Monitoring Iron Levels in Icelandic Blood Donors Improves Management

Repeat blood donors may deplete their iron stores.  The risk of iron-deficiency anemia in blood donors depends on gender, age,…

March 23, 2022

Fear and Anxiety Associated with Attrition of First-Time Donors

In order to tease apart whether fear and anxiety in first-time blood donors actually led to fewer return donations, researchers…

October 6, 2021

SARS-CoV-2 Seroprevalence in Blood Donors

The U.S. Centers for Disease Control (CDC) along with researchers from the National Heart, Lung, and Blood Institute and blood…

September 8, 2021

Donor Interventions Increase Donor’s Return for Future Donations

Donors who experience a vasovagal reaction are less likely to return for subsequent donations, and this is especially true in…

September 1, 2021

SARS-CoV-2 Seropositivity of U.S. Blood Donors Prior to Availability of Vaccines

In the United States, blood collection organizations, including the American Red Cross (ARC), started testing all donations for antibodies to…

August 18, 2021

Tracking HIV Drug Resistance and Subtypes in Blood Donors

The risk of HIV transmission from blood transfusion is low (0.16 to 0.49 per million transfusions) but is still possible…

June 22, 2021

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Interim pages omitted …
  • Page 13
  • Go to Next Page »

Primary Sidebar

Latest News

  • Mitochondrial DNA Acts as a “First Hit” for Antibody-Mediated TRALI

  • Liberal or Restrictive Transfusion Thresholds for Surgery Patients with High Cardiac Risk

  • Iron Supplementation for Blood Donors Based on Ferritin Levels

  • Impact of Individual Donor Assessment Deferral Changes on Donor HIV, HBV, HCV, and Syphilis Prevalence

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley